Macquarie Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $119M | Sell |
1,958,745
-57,459
| -3% | -$3.35M | 0.71% | 25 |
|
|
2025
Q4 | $109M | Buy |
2,016,204
+39,889
| +2% | +$1.92M | 0.48% | 40 |
|
|
2025
Q3 | $89.1M | Buy |
1,976,315
+46,915
| +2% | +$2.19M | 0.1% | 260 |
|
|
2025
Q2 | $89.3M | Buy |
1,929,400
+111,088
| +6% | +$5.45M | 0.11% | 265 |
|
|
2025
Q1 | $111M | Buy |
1,818,312
+83,948
| +5% | +$4.89M | 0.14% | 206 |
|
|
2024
Q4 | $93.6M | Buy |
1,734,364
+231,021
| +15% | +$12.9M | 0.11% | 254 |
|
|
2024
Q3 | $77.8M | Buy |
1,503,343
+75,309
| +5% | +$3.53M | 0.08% | 325 |
|
|
2024
Q2 | $59.3M | Sell |
1,428,034
-84,493
| -6% | -$3.78M | 0.07% | 371 |
|
|
2024
Q1 | $82M | Sell |
1,512,527
-2,678
| -0.2% | -$136K | 0.09% | 272 |
|
|
2023
Q4 | $77.7M | Buy |
1,515,205
+53,823
| +4% | +$2.83M | 0.09% | 308 |
|
|
2023
Q3 | $84.8M | Buy |
1,461,382
+9,782
| +0.7% | +$599K | 0.11% | 258 |
|
|
2023
Q2 | $92.8M | Sell |
1,451,600
-50,577
| -3% | -$3.39M | 0.11% | 251 |
|
|
2023
Q1 | $104M | Buy |
1,502,177
+2,264
| +0.2% | +$160K | 0.12% | 221 |
|
|
2022
Q4 | $108M | Buy |
1,499,913
+19,487
| +1% | +$1.47M | 0.13% | 221 |
|
|
2022
Q3 | $105M | Buy |
1,480,426
+10,932
| +0.7% | +$793K | 0.13% | 211 |
|
|
2022
Q2 | $113M | Sell |
1,469,494
-5,728
| -0.4% | -$436K | 0.13% | 208 |
|
|
2022
Q1 | $108K | Sell |
1,475,222
-187,541
| -11% | -$12.6M | 0.08% | 276 |
|
|
2021
Q4 | $104M | Buy |
1,662,763
+4,131
| +0.2% | +$242K | 0.09% | 295 |
|
|
2021
Q3 | $98.1M | Buy |
1,658,632
+460,092
| +38% | +$30.3M | 0.08% | 305 |
|
|
2021
Q2 | $80.1M | Buy |
1,198,540
+101,866
| +9% | +$6.64M | 0.07% | 375 |
|
|
2021
Q1 | $69.2M | Buy |
1,096,674
+535,785
| +96% | +$33.3M | 0.1% | 257 |
|
|
2020
Q4 | $34.8M | Sell |
560,889
-265,575
| -32% | -$16.3M | 0.05% | 389 |
|
|
2020
Q3 | $49.8M | Buy |
826,464
+169,812
| +26% | +$10.2M | 0.08% | 263 |
|
|
2020
Q2 | $38.6M | Sell |
656,652
-7,679
| -1% | -$459K | 0.07% | 301 |
|
|
2020
Q1 | $37M | Sell |
664,331
-28,517
| -4% | -$1.74M | 0.08% | 276 |
|
|
2019
Q4 | $44.5M | Buy |
692,848
+502,961
| +265% | +$28.8M | 0.06% | 325 |
|
|
2019
Q3 | $9.63M | Sell |
189,887
-564
| -0.3% | -$26.5K | 0.02% | 605 |
|
|
2019
Q2 | $8.64M | Buy |
190,451
+13,707
| +8% | +$638K | 0.01% | 638 |
|
|
2019
Q1 | $8.43M | Buy |
176,744
+1,080
| +0.6% | +$53.8K | 0.01% | 652 |
|
|
2018
Q4 | $9.13M | Sell |
175,664
-11,336
| -6% | -$609K | 0.02% | 610 |
|
|
2018
Q3 | $11.6M | Sell |
187,000
-8,000
| -4% | -$475K | 0.02% | 610 |
|
|
2018
Q2 | $10.8M | Buy |
195,000
+1,300
| +0.7% | +$70.2K | 0.02% | 619 |
|
|
2018
Q1 | $12.3M | Sell |
193,700
-5,900
| -3% | -$380K | 0.02% | 575 |
|
|
2017
Q4 | $12.4M | Sell |
199,600
-40,934
| -17% | -$2.56M | 0.02% | 591 |
|
|
2017
Q3 | $15.3M | Sell |
240,534
-31,748
| -12% | -$1.85M | 0.03% | 514 |
|
|
2017
Q2 | $15.2M | Sell |
272,282
-56,835
| -17% | -$3.09M | 0.03% | 514 |
|
|
2017
Q1 | $17.9M | Sell |
329,117
-81,839
| -20% | -$4.49M | 0.03% | 480 |
|
|
2016
Q4 | $24M | Sell |
410,956
-377,499
| -48% | -$20.6M | 0.05% | 383 |
|
|
2016
Q3 | $42.5M | Sell |
788,455
-1,157,343
| -59% | -$74.3M | 0.08% | 211 |
|
|
2016
Q2 | $143M | Buy |
1,945,798
+1,097,242
| +129% | +$77.5M | 0.14% | 121 |
|
|
2016
Q1 | $54.2M | Buy |
848,556
+14,440
| +2% | +$911K | 0.11% | 145 |
|
|
2015
Q4 | $57.4M | Buy |
834,116
+63,560
| +8% | +$4.2M | 0.12% | 143 |
|
|
2015
Q3 | $45.6M | Buy |
770,556
+29,829
| +4% | +$1.89M | 0.1% | 181 |
|
|
2015
Q2 | $49.3M | Buy |
740,727
+255,784
| +53% | +$16.9M | 0.1% | 188 |
|
|
2015
Q1 | $31.3M | Buy |
484,943
+95,100
| +24% | +$5.95M | 0.06% | 303 |
|
|
2014
Q4 | $23M | Sell |
389,843
-2,677
| -0.7% | -$151K | 0.05% | 353 |
|
|
2014
Q3 | $20.1M | Buy |
392,520
+37,914
| +11% | +$1.89M | 0.04% | 374 |
|
|
2014
Q2 | $17.2M | Buy |
354,606
+44,920
| +15% | +$2.21M | 0.04% | 390 |
|
|
2014
Q1 | $16.1M | Sell |
309,686
-86,680
| -22% | -$4.61M | 0.03% | 390 |
|
|
2013
Q4 | $21.1M | Buy |
396,366
+17,923
| +5% | +$913K | 0.04% | 322 |
|
|
2013
Q3 | $17.5M | Buy |
378,443
+103,637
| +38% | +$4.55M | 0.03% | 349 |
|
|
2013
Q2 | $12.3M | Buy |
+274,806
| New | +$11.9M | 0.03% | 397 |
|
Other funds holding BMY
VCM
VPM
Macquarie Group's BMY Position: Q1 2026 in Review
Macquarie Group reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q1 2026, selling an estimated $3.35M and leaving 1,958,745 shares worth $119M. The position accounts for 0.71% of the portfolio, ranked #25.
Macquarie Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $143M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Macquarie Group held 1,958,745 shares of Bristol-Myers Squibb worth $119M as of Q1 2026.
- Macquarie Group sold 57,459 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.35M.
- Bristol-Myers Squibb made up 0.71% of Macquarie Group's portfolio in Q1 2026, its #25 holding.
- Macquarie Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Macquarie Group's Bristol-Myers Squibb position peaked at $143M in Q2 2016.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.